Open access
Jul 2026
Exploring the therapeutic potential of NCX1 in hematological cancers; integration of molecular docking, bioinformatics approaches, and experimental validation.
Findings have demonstrated NCX1 as a biologically informative marker of myeloid differentiation and a promising therapeutic weak point within calcium signaling networks in hematological malignancies, providing a rationale for future functional and single-cell validation studies.
Sema Mısır, S. Yaman, Nina Petrović et al.
· Biochemical and Biophysical... · 0 citations